Genetically Targeted Clinical Trials in Parkinson’s Disease: Learning from the Successes Made in Oncology

Clinical trials in neurodegenerative disorders have been associated with high rate of failures, while in oncology, the implementation of precision medicine and focus on genetically defined subtypes of disease and targets for drug development have seen an unprecedented success. With more than 20 gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjögren, Magnus, Huttunen, Henri J., Svenningsson, Per, Widner, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535305/
https://www.ncbi.nlm.nih.gov/pubmed/34680924
http://dx.doi.org/10.3390/genes12101529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535305/
https://www.ncbi.nlm.nih.gov/pubmed/34680924
http://dx.doi.org/10.3390/genes12101529

Ejemplares similares